Blog

Nov 8, 2024, 18:44

Mamtha Balla: Tackling TIL therapy challenges in COVID-19

Mamtha Balla, Transplant Oncology-ID fellow at MD Anderson Cancer Center, shared a post on X:

”I am excited to present our Supriya Peshin poster on Tackling TIL therapy challenges in COVID-19 patients at the IOTOX symposium in Houston MD Anderson Cancer Center, Texas!

I’m thrilled to express my gratitude to IOTOX for allowing me to spotlight an incredibly significant topic—TIL, which has just received approval for solid cancers in February 2024!

It’s vital to grasp the distinctions between CART and TIL, and we must also navigate patient care for those with COVID-19 amidst these advancements. The possibilities in this field are fascinating!

Thanks to my mentors Pablo Okhuysen and Javier Adachi, Roy Chemaly for supporting me!”

cancer CART COVID-19 H.O.M.E Hem-Onc Fellows Network Houston IMG Oncologists IOTOX symposium IOTOX2024 Javier Adachi Mamtha Balla MD Anderson Cancer Center OncoDaily Oncology Pablo Okhuysen Roy Chemaly SITC 2024 Supriya Peshin Texas TIL TIL Therapy UTHealth Houston Infectious Diseases Women in Oncology

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage